{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:18Z","timestamp":1707524478488},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,28]]},"DOI":"10.7759\/cureus.23566","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T13:24:37Z","timestamp":1648473877000},"source":"Crossref","is-referenced-by-count":0,"title":["Improved Neurological Outcome in a Patient With Complicated Mitral Valve Endocarditis Treated With Daptomycin-Rifampin Regimen"],"prefix":"10.7759","author":[{"given":"Syed S","family":"Fatmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela","family":"Basso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravitej","family":"Goteti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.000813","article-title":"Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study","volume":"127","author":"Garc\u00eda-Cabrera E","year":"2013","unstructured":"Garc\u00eda-Cabrera E, Fern\u00e1ndez-Hidalgo N, Almirante B, et al.. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013, 127:2272-84. 10.1161\/CIRCULATIONAHA.112.000813","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.1.75","article-title":"Changing profile of infective endocarditis: results of a 1-year survey in France","volume":"288","author":"Hoen B","year":"2002","unstructured":"Hoen B, Alla F, Selton-Suty C, et al.. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002, 288:75-81. 10.1001\/jama.288.1.75","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/heart.88.1.53","article-title":"Mortality from infective endocarditis: clinical predictors of outcome","volume":"88","author":"Wallace SM","year":"2002","unstructured":"Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002, 88:53-60. 10.1136\/heart.88.1.53","journal-title":"Heart"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks467","article-title":"Daptomycin for the treatment of infective endocarditis: results from a European registry","volume":"68","author":"Dohmen PM","year":"2013","unstructured":"Dohmen PM, Guleri A, Capone A, et al.. Daptomycin for the treatment of infective endocarditis: results from a European registry. J Antimicrob Chemother. 2013, 68:936-42. 10.1093\/jac\/dks467","journal-title":"J Antimicrob Chemother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-007-0458-2","article-title":"Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis","volume":"27","author":"Hill EE","year":"2008","unstructured":"Hill EE, Peetermans WE, Vanderschueren S, Claus P, Herregods MC, Herijgers P. Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis. Eur J Clin Microbiol Infect Dis. 2008, 27:445-50. 10.1007\/s10096-007-0458-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.18.2781","article-title":"Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland","volume":"160","author":"Heiro M","year":"2000","unstructured":"Heiro M, Nikoskelainen J, Engblom E, Kotilainen E, Marttila R, Kotilainen P. Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med. 2000, 160:2781-7. 10.1001\/archinte.160.18.2781","journal-title":"Arch Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060195","article-title":"Clinical relevance of vegetation localization by transoesophageal echocardiography in infective endocarditis","volume":"13","author":"Rohmann S","year":"1992","unstructured":"Rohmann S, Erbel R, G\u00f6rge G, et al.. Clinical relevance of vegetation localization by transoesophageal echocardiography in infective endocarditis. Eur Heart J. 1992, 13:446-52. 10.1093\/oxfordjournals.eurheartj.a060195","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00226-10","article-title":"Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus","volume":"54","author":"Garrig\u00f3s C","year":"2010","unstructured":"Garrig\u00f3s C, Murillo O, Euba G, et al.. Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2010, 54:5251-6. 10.1128\/AAC.00226-10","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-014-0055-5","article-title":"Evaluation of high-dose daptomycin versus vancomycin alone or combined with clarithromycin or rifampin against Staphylococcus aureus and S. epidermidis in a novel in vitro PK\/PD model of bacterial biofilm","volume":"4","author":"Hall Snyder AD","year":"2014","unstructured":"Hall Snyder AD, Vidaillac C, Rose W, McRoberts JP, Rybak MJ. Evaluation of high-dose daptomycin versus vancomycin alone or combined with clarithromycin or rifampin against Staphylococcus aureus and S. epidermidis in a novel in vitro PK\/PD model of bacterial biofilm. Infect Dis Ther. 2014, 4:51-65. 10.1007\/s40121-014-0055-5","journal-title":"Infect Dis Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026997","article-title":"Mechanism of action and resistance to daptomycin in Staphylococcus aureus and Enterococci","volume":"6","author":"Miller WR","year":"2016","unstructured":"Miller WR, Bayer AS, Arias CA. Mechanism of action and resistance to daptomycin in Staphylococcus aureus and Enterococci. Cold Spring Harb Perspect Med. 2016, 6:a026997. 10.1101\/cshperspect.a026997","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.09.017","article-title":"Comparative effectiveness of vancomycin versus daptomycin for MRSA bacteremia with vancomycin MIC >1 mg\/L: a multicenter evaluation","volume":"38","author":"Moise PA","year":"2016","unstructured":"Moise PA, Culshaw DL, Wong-Beringer A, et al.. Comparative effectiveness of vancomycin versus daptomycin for MRSA bacteremia with vancomycin MIC >1 mg\/L: a multicenter evaluation. Clin Ther. 2016, 38:16-30. 10.1016\/j.clinthera.2015.09.017","journal-title":"Clin Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir764","article-title":"Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study","volume":"54","author":"Moore CL","year":"2012","unstructured":"Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Clin Infect Dis. 2012, 54:51-8. 10.1093\/cid\/cir764","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/65982-improved-neurological-outcome-in-a-patient-with-complicated-mitral-valve-endocarditis-treated-with-daptomycin-rifampin-regimen","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:33Z","timestamp":1707507753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/65982-improved-neurological-outcome-in-a-patient-with-complicated-mitral-valve-endocarditis-treated-with-daptomycin-rifampin-regimen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.23566","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,28]]}}}